KAM

Krensavage Asset Management Portfolio holdings

AUM $189M
This Quarter Return
+12.03%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$293M
AUM Growth
+$293M
Cap. Flow
+$10.6M
Cap. Flow %
3.6%
Top 10 Hldgs %
94.86%
Holding
14
New
4
Increased
1
Reduced
7
Closed
2

Top Buys

1
REGN icon
Regeneron Pharmaceuticals
REGN
$39.2M
2
TARO
Taro Pharmaceutical Industries Ltd.
TARO
$29.9M
3
ALKS icon
Alkermes
ALKS
$18.5M
4
ANAB icon
AnaptysBio
ANAB
$7.16M
5
ALXN
Alexion Pharmaceuticals Inc
ALXN
$6.33M

Top Sells

1
GILD icon
Gilead Sciences
GILD
$27.9M
2
ELAN icon
Elanco Animal Health
ELAN
$23.7M
3
BIIB icon
Biogen
BIIB
$19.8M
4
UTHR icon
United Therapeutics
UTHR
$6.97M
5
MCK icon
McKesson
MCK
$5.39M

Sector Composition

1 Healthcare 97.29%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$13.8B
$40.6M 13.85% 460,944 -79,150 -15% -$6.97M
REGN icon
2
Regeneron Pharmaceuticals
REGN
$61.5B
$39.2M 13.38% +104,420 New +$39.2M
MCK icon
3
McKesson
MCK
$85.4B
$35.2M 12% 254,330 -38,967 -13% -$5.39M
ALXN
4
DELISTED
Alexion Pharmaceuticals Inc
ALXN
$33.9M 11.57% 313,556 +58,556 +23% +$6.33M
BIIB icon
5
Biogen
BIIB
$19.4B
$32.6M 11.13% 109,904 -66,806 -38% -$19.8M
ENTA icon
6
Enanta Pharmaceuticals
ENTA
$180M
$30.2M 10.32% 489,385 -9,489 -2% -$586K
TARO
7
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$29.9M 10.2% +339,819 New +$29.9M
ALKS icon
8
Alkermes
ALKS
$4.78B
$18.5M 6.3% +905,078 New +$18.5M
SRGA
9
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$9.94M 3.39% 3,628,963 -261,361 -7% -$716K
IVC
10
DELISTED
Invacare Corporation
IVC
$7.94M 2.71% 880,402 -344,359 -28% -$3.11M
GILD icon
11
Gilead Sciences
GILD
$140B
$7.92M 2.7% 121,861 -429,854 -78% -$27.9M
ANAB icon
12
AnaptysBio
ANAB
$569M
$7.16M 2.44% +440,409 New +$7.16M
AVNS icon
13
Avanos Medical
AVNS
$554M
– – -59,429 Closed -$2.23M
ELAN icon
14
Elanco Animal Health
ELAN
$9.12B
– – -892,620 Closed -$23.7M